Clinical Trial Update: Rectal Tacrolimus in the Treatment of Resistant Ulcerative Proctitis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating rectal tacrolimus for resistant ulcerative proctitis (a form of ulcerative colitis) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis
• Ulcerative Proctitis

Drugs mentioned

• Tacrolimus (rectal formulation) (Tacrolimus)

Snippet

Sponsor: The University of Western Australia | Conditions: Ulcerative Colitis | Phase 4 | Status: COMPLETED